Синдром поликистозных яичников - 80 лет исследований и новые направления в изучении данного вопроса (обзор литературы)

В статье представлены актуальные данные истории изучения синдрома поликистозных яичников (СПКЯ). Отражены исследования генетической предрасположенности СПКЯ. Освещены этнические различия в фенотипических проявлениях СПКЯ, связь симптомов СПКЯ с развитием тревожно-депрессивных расстройств. Обсуждаются теории возникновения СПКЯ, в том числе теория связи СПКЯ с нарушениями бактериальной флоры кишечника, а также представлен обзор различных научных исследований в этой области.

СПКЯ, синдром Штейна - Левенталя, бесплодие, олигоменорея, инсулинорезистентность, гиперандрогения, гирсутизм, поликистозные яичники, кишечная микробиота

1. Алиева Э.А., Овсянникова Т.В., Пшеничникова Т.Я. Бесплодие, обусловленное синдромом поликистозных яичников // Акушерство и гинекология. -1991. - № 6. - С. 59-62

2. Алиева Э.А., Пшеничникова Т.Я., Гаспаров А.С. Патофизиология синдрома поликистозных яичников // Акушерство и гинекология. - 1989. - № 4. - С. 4-5

3. Назаренко Т.А., Сотникова Е.И., Дуринян Э.Р. Принципы и схемы стимуляции овуляции при бесплодии, обусловленном нарушениями функции гипоталамо-гипофизарной системы // Акушерство и гинекология. - 1996. - № 5. - С. 46-50

4. Серов В.Н., Прилепская В.Н., Пшеничникова Т.Я. Практическое руководство по гинекологической эндокринологии. - М.: Русфармомед, 1995. - 440 с

5. Шипхинеева Т.И., Сутурина Л.В., Даржаев З.Ю., Цыренов Т.Б., Ринчиндоржиева М.П. Характеристика причин эндокринного бесплодия у русских и буряток по данным обращаемости // Бюллетень ВСНЦ СО РАМН. - 2010. - № 6. - С. 99-101

6. Шулунов С.С., Шенин В.А., Колесникова Л.И., Лабыгина А.В., Сутурина Л.В., Большакова С.Е. Роль полиморфных генов в развитии синдрома поликистозных яичников // Сибирский медицинский журнал. - 2011. - № 7 (106). - С. 5-8

7. Ahima R.S., Flier J.S. (2000). Adipose tissue as an endocrine organ. Trends Endocrinology Metabolism, (11), 327-332.

8. Arusoglu G., Koksal G., Cinar N., Tapan S., Aksoy D.Y., Yildiz B.O. (2013). Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive. The Journal of Clinical Endocrinology and Metabolism, (11), 82.

9. Azziz R., Adashi E.Y. (2016). Stein and Leventhal: 80 years on. Obstetrics Gynecology, (2), 247.

10. Bhattacharya S., Jha A. (2010). Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS). Fertility & Sterility, (94), 357.

11. Cooper H.E., Spellacy W.N., Prem K.A., Cohen W.D. (1968). Hereditary factors in Stein-Levental syndrome. Obstetrics Gynecology, (7), 371-387.

12. Deeks A., Gibson-Helm M., Teede H. (2010). Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertility & Sterility, (93), 242.

13. Elting M.W., Korsen T.J., Bezemer P.D., Schoemaker J. (2001). Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Human Reproduction, (16), 556-560.

14. Fauser B.C., Tarlatzis B.C., Rebar R.W. (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Spon-sored 3rd PCOS Consensus Workshop Group. Fertility & Sterility (97), 28-38.

15. Foster G.D., Sanders M.H., Millman R., Zammit G., Borradaile K.E., Newman A.B., Wadden T.A., Kelley D., Wing R.R., Sunyer F.X., Darcey V., Kuna S.T. (2009). Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care, (32), 1017-1019.

16. Hahn S., Haselhorst U., Quadbeck B., Tan S., Kimmig R., Mann K., Janssen O.E. (2006). Decreased soluble leptin receptor levels in women with polycystic ovary syndrome. Endocrinology (154), 287-294.

17. Hla K.M., Young T., Finn L., Peppard P.E., Szklo-Coxe M., Stubbs M. (2008). Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Endocrinology, (31), 795-800.

18. Mаnsson M. (2008). Women with polycystic ovary syndrome are often depressed or anxious-A case control study. Psychoneuroendocrinology, (33), 1132-1138.

19. Moran L.J., Noakes M., Clifton P.M., Wittert G.A., Le Roux C.W., Ghatei M.A., Bloom S.R., Norman R.J. (2007). Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. The American Journal of Clinical Nutrition, 86 (6), 1603-1610.

20. Nobels F., Dewailly D. (1992). Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor hypothesis. Fertility & Sterility, (4), 655-666.

21. Oei M., Kazer R. (1992). Variability of serum gonadotropin and dehydroepiandrosterone sulfate concentrations in women with polycystic ovary syndrome. Iranian Journal of Reproductive Medicine, (12), 974-979.

22. Pirwany I.R., Fleming R., Sattar N., Greer I.A., Wallace A.M. (2001). Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. Endocrinology, (145), 289-294.

23. Pusalkar M., Meherji P., Gokral J., Savardekar L., Chinnaraj S., Maitra A. (2010). Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes. Gynecology & Endocrinology, (26), 874-882.

24. Randeva H.S., Таn B.K., Weickert M.O., Lois K., Nestler J.E., Sattar N., Lehnert H. (2012). Cardiometabolic aspects of the polycystic ovary syndrome. Review of Endocrinology, 33 (5), 812-41.

25. Sattar N., Wannamethee G., Sarwar N., Chernova J., Lawlor D.A., Kelly A., Wallace A.M., Danesh J., Whincup P.H. (2009). Leptin and coronary heart disease: prospective study and systematic review. Journal of the American College of Cardiology, (153), 167-175.

26. Scott T. Kelley, Skarra D.V., Rivera A.J., Thackray V.G. (2016). The gut microbiome is altered in a letro-zole-induced mouse model of polycystic ovary syndrome, PLoS ONE, (1) 5; 11 (1). doi: 10.1371/journal. pone.0146509.

27. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., Daniels S., Floras J.S., Hunt C.E., Olson L.J., Pickering T.G., Russell R., Woo M., Young T. (2008). Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. Journal of the American College of Cardiology, (52), 686-717.

28. Stein I.F., Levinthal M.L. (1935). Amenorrhea associated with bilateral polycystic ovaries, Obstetrics Gynecology, (29), 181-191.

29. Tasali E., Chapotot F., Leproult R., Whitmore H., Ehrmann D.A. (2011). Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism (96), 365-374.

30. Tasali E., Mokhlesi B., Van Cauter E. (2008). Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest Journal, (133), 496-506

31. Tremellen K., Pearce K. (2012) Dysbiosis of Gut Microbiota (DOGMA) - a novel theory for the development of Polycystic Ovarian Syndrome. Medical Hypotheses, 79 (1), 104. doi: 10.1016/j.mehy.2012.04.016 [Pub Med].

32. Tsilchorozidou T., Batterham R.L., Conway G.S. (2008). Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS). Clinical Endocrinology, 69 (6), 936-942.

33. Vgontzas A.N., Legro R.S., Bixler E.O., Grayev A., Kales A., Chrousos G.P. (2001). Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. The Journal of Clinical Endocrinology and Metabolism, (86), 517-520.

34. Vrbi'kova J., Ci'fkova R., Jirkovska A., Lanska V., Platilova H., Zamrazil V., Starka L. (2003). Cardiovascular risk factors in young Czech females with polycystic ovary syndrome. Human Reproduction, (18), 980-984.

35. Yildizhan R., Ilhan G.A., Yildizhan B., Kolusari A., Adali E., Bugdayci G. (2011). Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylargi-nine levels in obese and nonobese young women with polycystic ovary syndrome. Fertility & Sterility, (96), 246-250.

36. Zhao L., Guo Y., Qi Y., Yang X., Wen S., Liu Y., Tang L. (2016). Association between Polycystic Ovary Syndrome and Gut Microbiota, PLoS ONE, 11 (4), doi: 10.1371/ journal.pone.0153196 [Pub Med].

37. Zhao Y., Qiao J. (2013). Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids, (78), 755-760.

38. Weickert M.O., Hodges P., Tan B.K., Randeva H.S. (2012). Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin. Minerva Endocrinologica, 37 (1), 25-40.